What antibiotics can cause myoclonus and jerking movements?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluoroquinolones Are the Primary Antibiotics That Cause Myoclonus and Jerking Movements

Fluoroquinolone antibiotics are the most well-documented class of antibiotics associated with myoclonus and jerking movements, with ciprofloxacin having the strongest evidence for causing these neurological adverse effects. 1

Fluoroquinolones and Neurological Effects

  • Fluoroquinolones can cause a variety of muscle syndromes ranging from mild myalgias to severe manifestations including myoclonus and jerking movements 2
  • These neurological adverse effects typically manifest within one week after starting fluoroquinolone treatment 2
  • Symptoms often resolve within 1-4 weeks after discontinuation of the medication, though some cases have persisted for up to 6 months 2
  • The fluorine atom in fluoroquinolones is thought to be a key trigger for these muscle disorders 2

Specific Fluoroquinolones Associated with Myoclonus

  • Ciprofloxacin has level A evidence (highest level) for causing myoclonus according to systematic reviews 1
  • Levofloxacin has been specifically documented to cause reversible myoclonus/chorea in case reports 3
  • Ofloxacin and norfloxacin have been associated with muscle disorders including myoclonus 2

Pathophysiological Mechanisms

  • The etiology of fluoroquinolone-associated muscle disorders appears to be related to:
    1. Possible latent myopathic disorders that are revealed by fluoroquinolone exposure 2
    2. Metabolic abnormalities in muscle tissue that can be detected through specialized testing 2
    3. Interaction with neurotransmitter systems including serotonin, dopamine, GABA, and glutamate 1

Risk Factors for Developing Myoclonus with Fluoroquinolones

  • Pre-existing muscular anomalies or myopathic processes 2, 4
  • Concurrent use of statins significantly increases the risk of muscle-related adverse effects 2, 4
  • Renal disease or impairment 4
  • Advanced age 4
  • History of malignant hyperthermia susceptibility 2

Clinical Presentation

  • Symptoms typically consist of diffuse muscle pain with or without weakness 2
  • There may be a predilection for proximal muscle groups 2
  • Jerking movements can range from mild to severe and disabling 5
  • Myoclonus presents as quick, simple jerks, while chorea combines with other, slower movements in a continuous, flowing fashion 6

Management Recommendations

  • Immediately discontinue the fluoroquinolone if myoclonus or other muscle symptoms develop 2, 4
  • Protect the affected area to limit further injury 2
  • For treatment of established myoclonus:
    • Levetiracetam, valproic acid, and clonazepam are first-line agents for cortical myoclonus 7
    • Clonazepam is the first-line agent for subcortical, brainstem, and spinal myoclonus 7
    • Avoid phenytoin and carbamazepine as they may paradoxically worsen myoclonus 7

Prevention Strategies

  • Use alternative antibiotics in patients with risk factors when possible 4
  • Avoid concomitant corticosteroid administration with fluoroquinolones 2, 4
  • Limit high-intensity physical activity during fluoroquinolone treatment 2
  • Consider magnesium supplementation during treatment (administered at different times than the fluoroquinolone to avoid decreased antibiotic efficacy) 4

Important Caveats

  • The onset of myoclonus can be rapid and may occur even in patients without prior neurological disorders 3
  • Myoclonus may persist for weeks to months after discontinuation of the fluoroquinolone 2
  • Patients taking both fluoroquinolones and statins should be monitored particularly closely for muscle-related adverse effects 2, 4
  • There are no FDA-approved medications specifically for drug-induced myoclonus, and most therapies are borrowed from antiepileptic and psychiatric treatments 5

References

Research

Drug-Induced Myoclonus: A Systematic Review.

Medicina (Kaunas, Lithuania), 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A Rare Instance of Levofloxacin Induced Myoclonus.

Journal of clinical and diagnostic research : JCDR, 2017

Guideline

Fluoroquinolone-Associated Risks and Precautions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Myoclonus.

Current opinion in neurology, 2003

Research

Myoclonus: Pathophysiology and Treatment Options.

Current treatment options in neurology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.